Sampre Nutritions Closes Trading Window for Q1 FY27 Results

Sampre Nutritions Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's code of conduct, specifically for the announcement of unaudited standalone and consolidated financial results for the first quarter of the financial year 2026-27, ending on June 30, 2026. The trading window will remain shut from July 1, 2026, until 48 hours after the declaration of these financial results. The exact date of the Board of Directors' meeting to approve these results will be communicated later. Promoters, directors, designated persons, and their immediate relatives are prohibited from trading during this period.